NASDAQ:SPNE - SeaSpine Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$11.87 -0.16 (-1.33 %)
(As of 05/20/2018 04:00 PM ET)
Previous Close$11.87
Today's Range$11.63 - $12.32
52-Week Range$8.76 - $13.76
Volume33,187 shs
Average Volume29,239 shs
Market Capitalization$172.54 million
P/E Ratio-4.60
Dividend YieldN/A
Beta0.31

About SeaSpine (NASDAQ:SPNE)

SeaSpine logoSeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical regions of the spine. Its orthobiologics products include demineralized bone matrices, collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to enhance bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company offers orthobiologics products in various forms, such as putties, pastes, strips, and resorbable mesh. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in minimally invasive, complex, deformity, and degenerative procedures. The company was incorporated in 2015 and is headquartered in Carlsbad, California.

Receive SPNE News and Ratings via Email

Sign-up to receive the latest news and ratings for SPNE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SPNE
CUSIPN/A
Phone760-727-8399

Debt

Debt-to-Equity RatioN/A
Current Ratio3.65
Quick Ratio1.63

Price-To-Earnings

Trailing P/E Ratio-4.60
Forward P/E Ratio-6.45
P/E GrowthN/A

Sales & Book Value

Annual Sales$131.81 million
Price / Sales1.31
Cash FlowN/A
Price / CashN/A
Book Value$7.40 per share
Price / Book1.60

Profitability

EPS (Most Recent Fiscal Year)($2.58)
Net Income$-32,110,000.00
Net Margins-22.63%
Return on Equity-28.04%
Return on Assets-21.85%

Miscellaneous

Employees327
Outstanding Shares14,540,000

SeaSpine (NASDAQ:SPNE) Frequently Asked Questions

What is SeaSpine's stock symbol?

SeaSpine trades on the NASDAQ under the ticker symbol "SPNE."

How were SeaSpine's earnings last quarter?

SeaSpine Holdings (NASDAQ:SPNE) announced its quarterly earnings data on Thursday, May, 3rd. The medical equipment provider reported ($0.50) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.53) by $0.03. The medical equipment provider earned $33.18 million during the quarter, compared to the consensus estimate of $32.75 million. SeaSpine had a negative return on equity of 28.04% and a negative net margin of 22.63%. View SeaSpine's Earnings History.

When is SeaSpine's next earnings date?

SeaSpine is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for SeaSpine.

What price target have analysts set for SPNE?

4 equities research analysts have issued 12 month price objectives for SeaSpine's stock. Their predictions range from $15.00 to $22.00. On average, they anticipate SeaSpine's stock price to reach $18.50 in the next twelve months. View Analyst Ratings for SeaSpine.

What are Wall Street analysts saying about SeaSpine stock?

Here are some recent quotes from research analysts about SeaSpine stock:
  • 1. According to Zacks Investment Research, "SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company also offers orthobiologics and spinal fusion hardware solutions. SeaSpine Holdings Corporation is headquartered in Vista, California. " (5/9/2018)
  • 2. BTIG Research analysts commented, "From New Products Should Set up FY18 SeaSpine ended FY17 with strength in Orthobiologics driving upside in the quarter. Revenue of $34.0M exceeded BTIG/Consensus original expectations of $33.2M. Guidance was maintained ($135M-$139M) but mgmt. provided further clarity on the cadence of revenue throughout the year. SPNE has been filling out its product portfolio with a variety of unique orthobiologic products which we believe should help to bolster growth. That said, the impact of these products will be felt in 2H18 where growth should approach double digits. In addition with recent added capital from a completed ATM, SPNE has the fire power to increase instrument sets in the field which should help the hardware business as well. Net, net we view the set-up for SPNE as attractive in FY18 as new products improve growth, instrument sets support distributors, and valuation remains reasonable.   Gross margins a standout. GMs of 63.3% were well ahead of our expectations and up ~460bps from the year ago quarter. Mgmt. is beginning to get leverage from its Irvine manufacturing facility as newer products comprise a larger portion of rev and can be manufactured at higher margins. FY18 GM guidance was set at 61%- 62%." (3/2/2018)

Who are some of SeaSpine's key competitors?

Who are SeaSpine's key executives?

SeaSpine's management team includes the folowing people:
  • Mr. Keith C. Valentine, Pres, Chief Exec. Officer & Director (Age 50)
  • Mr. John J. Bostjancic, Sr. VP & CFO (Age 47)
  • Mr. Patrick L. Keran, Gen. Counsel & Corp. Sec. (Age 46)
  • Mr. John J. Winge, VP of Sales (Age 51)
  • Mr. Tyler P. Lipschultz, Sr. VP of Orthobiologics & Bus. Devel. (Age 51)

Has SeaSpine been receiving favorable news coverage?

News headlines about SPNE stock have been trending somewhat positive on Sunday, Accern reports. The research group identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. SeaSpine earned a news sentiment score of 0.08 on Accern's scale. They also gave news headlines about the medical equipment provider an impact score of 47.92 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are SeaSpine's major shareholders?

SeaSpine's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.53%), BlackRock Inc. (3.06%), Russell Investments Group Ltd. (2.80%), The Manufacturers Life Insurance Company (2.63%) and Northern Trust Corp (0.24%). Company insiders that own SeaSpine stock include John J Bostjancic, Keith Valentine, Michael Fekete, Patrick L Keran and Stuart Essig. View Institutional Ownership Trends for SeaSpine.

Which institutional investors are selling SeaSpine stock?

SPNE stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc.. View Insider Buying and Selling for SeaSpine.

Which institutional investors are buying SeaSpine stock?

SPNE stock was purchased by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Russell Investments Group Ltd., Dimensional Fund Advisors LP and Northern Trust Corp. Company insiders that have bought SeaSpine stock in the last two years include John J Bostjancic, Keith Valentine, Michael Fekete and Stuart Essig. View Insider Buying and Selling for SeaSpine.

How do I buy shares of SeaSpine?

Shares of SPNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SeaSpine's stock price today?

One share of SPNE stock can currently be purchased for approximately $11.87.

How big of a company is SeaSpine?

SeaSpine has a market capitalization of $172.54 million and generates $131.81 million in revenue each year. The medical equipment provider earns $-32,110,000.00 in net income (profit) each year or ($2.58) on an earnings per share basis. SeaSpine employs 327 workers across the globe.

How can I contact SeaSpine?

SeaSpine's mailing address is 5770 ARMADA DRIVE, CARLSBAD CA, 92008. The medical equipment provider can be reached via phone at 760-727-8399 or via email at [email protected]


MarketBeat Community Rating for SeaSpine (SPNE)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  160
MarketBeat's community ratings are surveys of what our community members think about SeaSpine and other stocks. Vote "Outperform" if you believe SPNE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SPNE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

SeaSpine (NASDAQ:SPNE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for SeaSpine in the last 12 months. Their average twelve-month price target is $18.50, suggesting that the stock has a possible upside of 55.86%. The high price target for SPNE is $22.00 and the low price target for SPNE is $15.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $18.50$18.50$19.00$18.50
Price Target Upside: 55.86% upside86.68% upside90.76% upside81.19% upside

SeaSpine (NASDAQ:SPNE) Consensus Price Target History

Price Target History for SeaSpine (NASDAQ:SPNE)

SeaSpine (NASDAQ:SPNE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/4/2018HC WainwrightSet Price TargetBuy$15.00LowView Rating Details
3/2/2018BTIG ResearchReiterated RatingBuy$17.00LowView Rating Details
12/14/2017Ladenburg ThalmannInitiated CoverageBuy$20.00LowView Rating Details
8/20/2017Piper Jaffray CompaniesReiterated RatingBuy$22.00LowView Rating Details
(Data available from 5/20/2016 forward)

Earnings

SeaSpine (NASDAQ:SPNE) Earnings History and Estimates Chart

Earnings by Quarter for SeaSpine (NASDAQ:SPNE)

SeaSpine (NASDAQ:SPNE) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.84 EPS
Next Year EPS Consensus Estimate: $-1.33 EPS

SeaSpine (NASDAQ SPNE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018($0.48)N/AView Earnings Details
5/3/2018Q1 2018($0.53)($0.50)$32.75 million$33.18 millionViewN/AView Earnings Details
2/28/2018Q4 2017($0.52)($0.56)$33.98 millionViewListenView Earnings Details
11/2/2017Q3 2017($0.64)($0.58)$31.74 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.79)($0.68)$34.20 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.83)($0.79)$31.89 millionViewN/AView Earnings Details
3/2/2017Q4 2016($0.36)($0.8670)$32.52 millionViewListenView Earnings Details
11/9/2016Q3 2016($0.54)($0.84)$31.74 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.79)($1.07)$33.20 millionViewN/AView Earnings Details
5/12/2016Q1($0.89)($1.08)$31.40 millionViewListenView Earnings Details
3/15/2016Q4($0.90)($1.23)$34.70 millionViewListenView Earnings Details
11/12/2015Q315($0.60)($1.27)$33.23 million$32.70 millionViewListenView Earnings Details
8/13/2015Q215($0.20)($1.60)$34.11 million$33.50 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

SeaSpine (NASDAQ:SPNE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

SeaSpine (NASDAQ SPNE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 13.54%
Institutional Ownership Percentage: 38.55%
Insider Trading History for SeaSpine (NASDAQ:SPNE)
Institutional Ownership by Quarter for SeaSpine (NASDAQ:SPNE)

SeaSpine (NASDAQ SPNE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2017Michael FeketeDirectorBuy1,490$10.25$15,272.5032,304View SEC Filing  
11/8/2017Michael FeketeDirectorBuy560$10.25$5,740.0032,304View SEC Filing  
3/15/2017Michael FeketeDirectorBuy5,100$6.65$33,915.0015,110View SEC Filing  
3/13/2017Patrick L KeranVPSell6,315$6.66$42,057.9016,869View SEC Filing  
3/13/2017Stuart EssigDirectorBuy50,000$6.67$333,500.00378,946View SEC Filing  
11/18/2016John J BostjancicCFOBuy3,900$7.02$27,378.0022,025View SEC Filing  
11/18/2016Keith ValentineCEOBuy25,000$7.00$175,000.00101,417View SEC Filing  
5/23/2016Keith ValentineCEOBuy10,000$10.16$101,600.0070,100View SEC Filing  
5/20/2016John J BostjancicCFOBuy5,000$10.32$51,600.0023,072View SEC Filing  
9/2/2015John J BostjancicCFOBuy2,500$14.05$35,125.0022,398View SEC Filing  
8/20/2015Keith ValentineCEOBuy65,100$15.33$997,983.0065,100View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

SeaSpine (NASDAQ SPNE) News Headlines

Source:
DateHeadline
Zacks: Analysts Expect SeaSpine Holdings (SPNE) Will Announce Quarterly Sales of $34.12 MillionZacks: Analysts Expect SeaSpine Holdings (SPNE) Will Announce Quarterly Sales of $34.12 Million
www.americanbankingnews.com - May 20 at 3:58 AM
SeaSpine (SPNE) Rating Lowered to Hold at ValuEngineSeaSpine (SPNE) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - May 18 at 11:20 PM
 Brokerages Anticipate SeaSpine Holdings (SPNE) Will Post Earnings of -$0.49 Per Share Brokerages Anticipate SeaSpine Holdings (SPNE) Will Post Earnings of -$0.49 Per Share
www.americanbankingnews.com - May 18 at 11:57 AM
SeaSpine Holdings (SPNE) Given Consensus Recommendation of "Buy" by BrokeragesSeaSpine Holdings (SPNE) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 13 at 1:39 AM
SeaSpine (SPNE) vs. Restoration Robotics (HAIR) Head to Head ContrastSeaSpine (SPNE) vs. Restoration Robotics (HAIR) Head to Head Contrast
www.americanbankingnews.com - May 12 at 1:24 PM
BRIEF-Seaspine Holdings Says Entered Into Equity Distribution Agreement With Piper JaffrayBRIEF-Seaspine Holdings Says Entered Into Equity Distribution Agreement With Piper Jaffray
www.reuters.com - May 12 at 9:32 AM
SeaSpine (SPNE) Upgraded to Buy at Zacks Investment ResearchSeaSpine (SPNE) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - May 9 at 6:47 PM
Financial Contrast: Teleflex (TFX) and SeaSpine (SPNE)Financial Contrast: Teleflex (TFX) and SeaSpine (SPNE)
www.americanbankingnews.com - May 9 at 1:06 AM
ValuEngine Upgrades SeaSpine (SPNE) to BuyValuEngine Upgrades SeaSpine (SPNE) to Buy
www.americanbankingnews.com - May 8 at 11:26 PM
SeaSpine (SPNE) Stock Rating Lowered by Zacks Investment ResearchSeaSpine (SPNE) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - May 5 at 7:35 PM
SeaSpine Holdings (SPNE) CEO Keith Valentine on Q1 2018 Results - Earnings Call TranscriptSeaSpine Holdings' (SPNE) CEO Keith Valentine on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 9:19 AM
HC Wainwright Reiterates "Buy" Rating for SeaSpine (SPNE)HC Wainwright Reiterates "Buy" Rating for SeaSpine (SPNE)
www.americanbankingnews.com - May 4 at 3:17 PM
BRIEF-Seaspine Qtrly Net Loss Per Share, Basic And Diluted $0.50BRIEF-Seaspine Qtrly Net Loss Per Share, Basic And Diluted $0.50
www.reuters.com - May 4 at 8:59 AM
SeaSpine beats by $0.03, beats on revenueSeaSpine beats by $0.03, beats on revenue
seekingalpha.com - May 4 at 8:59 AM
Edited Transcript of SPNE earnings conference call or presentation 3-May-18 8:30pm GMTEdited Transcript of SPNE earnings conference call or presentation 3-May-18 8:30pm GMT
finance.yahoo.com - May 4 at 8:59 AM
SeaSpine (SPNE) Lifted to "Buy" at Zacks Investment ResearchSeaSpine (SPNE) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 3 at 11:02 PM
SeaSpine (SPNE) Posts Quarterly  Earnings Results, Beats Expectations By $0.01 EPSSeaSpine (SPNE) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - May 3 at 5:54 PM
SeaSpine Reports First Quarter 2018 Financial ResultsSeaSpine Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 3 at 4:45 PM
SeaSpine (SPNE) Upgraded by ValuEngine to BuySeaSpine (SPNE) Upgraded by ValuEngine to Buy
www.americanbankingnews.com - May 2 at 6:06 PM
Analyzing SeaSpine (SPNE) & Apollo Endosurgery (APEN)Analyzing SeaSpine (SPNE) & Apollo Endosurgery (APEN)
www.americanbankingnews.com - April 26 at 5:26 AM
SeaSpine (SPNE) Scheduled to Post Earnings on ThursdaySeaSpine (SPNE) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 26 at 2:17 AM
SeaSpine Holdings (SPNE) Given Average Rating of "Buy" by AnalystsSeaSpine Holdings (SPNE) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - April 18 at 1:48 AM
SeaSpine (SPNE) PT Set at $15.00 by HC WainwrightSeaSpine (SPNE) PT Set at $15.00 by HC Wainwright
www.americanbankingnews.com - April 13 at 12:25 AM
SeaSpine (SPNE) Upgraded at ValuEngineSeaSpine (SPNE) Upgraded at ValuEngine
www.americanbankingnews.com - April 3 at 12:00 AM
Edited Transcript of SPNE earnings conference call or presentation 28-Feb-18 9:30pm GMTEdited Transcript of SPNE earnings conference call or presentation 28-Feb-18 9:30pm GMT
finance.yahoo.com - April 1 at 9:06 AM
SeaSpine Holdings Corp (SPNE) Receives Consensus Rating of "Buy" from BrokeragesSeaSpine Holdings Corp (SPNE) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - March 24 at 9:56 AM
Head-To-Head Contrast: Hill-Rom (HRC) vs. SeaSpine (SPNE)Head-To-Head Contrast: Hill-Rom (HRC) vs. SeaSpine (SPNE)
www.americanbankingnews.com - March 13 at 1:57 PM
SeaSpine to Participate in the 38th Annual Cowen Healthcare ConferenceSeaSpine to Participate in the 38th Annual Cowen Healthcare Conference
finance.yahoo.com - March 7 at 5:40 PM
Financial Contrast: SeaSpine (SPNE) versus Tandem Diabetes Care (TNDM)Financial Contrast: SeaSpine (SPNE) versus Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - March 5 at 9:16 PM
SeaSpine (SPNE) Earns "Buy" Rating from BTIG ResearchSeaSpine (SPNE) Earns "Buy" Rating from BTIG Research
www.americanbankingnews.com - March 3 at 8:22 PM
HC Wainwright Reiterates $15.00 Price Target for SeaSpine (SPNE)HC Wainwright Reiterates $15.00 Price Target for SeaSpine (SPNE)
www.americanbankingnews.com - March 2 at 10:52 PM
SeaSpine reports 4Q lossSeaSpine reports 4Q loss
www.cnbc.com - March 1 at 8:51 AM
SeaSpine (SPNE) Releases Quarterly  Earnings Results, Misses Expectations By $0.03 EPSSeaSpine (SPNE) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS
www.americanbankingnews.com - February 28 at 7:04 PM
SeaSpine Announces Fourth Quarter and Full-Year 2017 Results and Issues 2018 Financial GuidanceSeaSpine Announces Fourth Quarter and Full-Year 2017 Results and Issues 2018 Financial Guidance
finance.yahoo.com - February 28 at 5:21 PM
SeaSpine Holdings Corp. to Host Earnings CallSeaSpine Holdings Corp. to Host Earnings Call
finance.yahoo.com - February 28 at 5:21 PM
SeaSpine Holdings Corp (SPNE) Receives Average Rating of "Buy" from BrokeragesSeaSpine Holdings Corp (SPNE) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 27 at 12:32 PM
-$0.52 EPS Expected for SeaSpine Holdings Corp (SPNE) This Quarter-$0.52 EPS Expected for SeaSpine Holdings Corp (SPNE) This Quarter
www.americanbankingnews.com - February 22 at 1:10 AM
SeaSpine to Report Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018SeaSpine to Report Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
finance.yahoo.com - February 21 at 4:58 PM
SeaSpine (SPNE) Scheduled to Post Earnings on WednesdaySeaSpine (SPNE) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - February 21 at 3:00 AM
Asante Solutions (PUMP) & SeaSpine (SPNE) Head to Head ComparisonAsante Solutions (PUMP) & SeaSpine (SPNE) Head to Head Comparison
www.americanbankingnews.com - February 6 at 5:10 PM
Head to Head Review: MiMedx Group (MDXG) and SeaSpine (SPNE)Head to Head Review: MiMedx Group (MDXG) and SeaSpine (SPNE)
www.americanbankingnews.com - February 6 at 1:14 AM
SeaSpine Holdings Corp (SPNE) Expected to Announce Earnings of -$0.52 Per ShareSeaSpine Holdings Corp (SPNE) Expected to Announce Earnings of -$0.52 Per Share
www.americanbankingnews.com - February 5 at 1:10 AM
Contrasting SurModics (SRDX) & SeaSpine (SPNE)Contrasting SurModics (SRDX) & SeaSpine (SPNE)
www.americanbankingnews.com - February 3 at 9:18 PM
SeaSpine Holdings Corp (SPNE) Given Consensus Rating of "Buy" by AnalystsSeaSpine Holdings Corp (SPNE) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - February 2 at 2:42 PM
SeaSpine Expands Ventura™ NanoMetalene® Implant Offering to Accommodate Larger Range of Posterior ProceduresSeaSpine Expands Ventura™ NanoMetalene® Implant Offering to Accommodate Larger Range of Posterior Procedures
finance.yahoo.com - January 31 at 9:50 AM
Analyzing C R Bard (BCR) and SeaSpine (SPNE)Analyzing C R Bard (BCR) and SeaSpine (SPNE)
www.americanbankingnews.com - January 22 at 8:26 AM
Zacks: Analysts Anticipate SeaSpine Holdings Corporation (SPNE) to Announce -$0.52 EPSZacks: Analysts Anticipate SeaSpine Holdings Corporation (SPNE) to Announce -$0.52 EPS
www.americanbankingnews.com - January 19 at 3:30 AM
SeaSpine Holdings (SPNE) Reports Prelim. 4Q & FY17 Revenues Above Consensus; Guides 2018 Revenue Mid-Point Outlook Slightly Above ConsensusSeaSpine Holdings (SPNE) Reports Prelim. 4Q & FY17 Revenues Above Consensus; Guides 2018 Revenue Mid-Point Outlook Slightly Above Consensus
www.streetinsider.com - January 8 at 4:06 PM
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2017SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2017
finance.yahoo.com - January 8 at 9:14 AM
SeaSpine Holdings Corporation (SPNE) Given Average Rating of "Buy" by AnalystsSeaSpine Holdings Corporation (SPNE) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - January 8 at 8:00 AM

SEC Filings

SeaSpine (NASDAQ:SPNE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

SeaSpine (NASDAQ:SPNE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

SeaSpine (NASDAQ SPNE) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.